PT  - JOURNAL ARTICLE
AU  - Butler, Tracy
AU  - Wang, X. Hugh
AU  - Chiang, Gloria C.
AU  - Li, Yi
AU  - Zhou, Liangdong
AU  - Xi, Ke
AU  - Wickramasuriya, Nimmi
AU  - Tanzi, Emily
AU  - Spector, Edward
AU  - Ozsahin, Ilker
AU  - Mao, Xiangling
AU  - Razlighi, Q. Ray
AU  - Fung, Edward K.
AU  - Dyke, Jonathan P.
AU  - Maloney, Thomas R.
AU  - Gupta, Ajay
AU  - Raj, Ashish
AU  - Shungu, Dikoma C.
AU  - Mozley, P. David
AU  - Rusinek, Henry
AU  - Glodzik, Lidia
TI  - Choroid Plexus calcification correlates with cortical microglial activation in humans: a multimodal PET, CT, MRI study
AID  - 10.1101/2022.11.14.22282263
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.11.14.22282263
4099  - http://medrxiv.org/content/early/2022/11/17/2022.11.14.22282263.short
4100  - http://medrxiv.org/content/early/2022/11/17/2022.11.14.22282263.full
AB  - Background Choroid plexus (CP) within brain ventricles is well-known to produce CSF. Additional important CP functions are now recognized including critical modulation of inflammation. Recent MRI studies have demonstrated CP enlargement in human diseases including Multiple Sclerosis and Alzheimer’s Disease, and in association with neuroinflammation measured using translocator protein (TSPO) PET. The basis of MRI-visible CP enlargement is unknown.Purpose Based on tissue studies demonstrating CP calcification as a common pathology associated with aging and disease, we hypothesized that previously-unmeasured calcium within CP contributes to MRI-measured CP volume, and may be more specifically associated with neuroinflammation.Materials and Methods We performed a retrospective analysis of PET-CT studies performed between 2013-2019 on a single scanner using the TSPO radiotracer 11C-PK11195. Subjects included controls (n=43) and patients diagnosed with several non-inflammatory neuropsychiatric conditions (n=46.) Cortical inflammation / microglial activation was quantified as non-displaceable Binding Potential (BPnd.) CP and ventricle volume were measured using Freesurfer. CP calcium was measured semi-manually via tracing of low-dose CT acquired with PET and automatically using a new CT/MRI method. The contribution of CP calcium, CP overall volume, ventricle volume, subject age, sex and diagnosis to BPnd was assessed using linear regression.Results 89 subjects (mean age 54+/-7 years; 52 men) were included. Fully-automated CP calcium quantification was accurate (ICC with semi-manual tracing = .98.) The significant predictors of cortical neuroinflammation were subject age (p=.002) and CP calcium volume (p=.041), but not ventricle or CP volume.Conclusion CP calcium volume can be accurately measured using low-dose CT acquired routinely with PET-CT. CP calcification – but not CP overall volume – was associated with cortical inflammation. Unmeasured CP calcification may be relevant to recent reports of CP enlargement in human inflammatory and other diseases. CP calcification may be a specific and relatively easily-acquired biomarker for neuroinflammation and CP pathology.Key ResultsChoroid plexus (CP) calcification volume can be reliably quantified using semi-manual tracing on low-dose CT acquired with PET-CT, and fully automatically using our new, accurate (ICC with semi-manual tracing = .98) CT/MRI method.CP calcification and age –but not overall CP volume– significantly predicted 11C-PK11195 PET-measured cortical neuroinflammation in 89 subjects.CP calcification is a relatively easily-assessed, previously-overlooked potential biomarker for neuroinflammation and CP pathology.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by NIH grants R01AG057681, K23NS057579, R01NS105541, R01NS092802, RF1AG062196, R01AG072753 and DOD grant: W81XWH-15-1-0437.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Weill Cornell Institutional Review Board gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors